Angiotensin I converting enzyme II
 | This article is a stub. |
Angiotensin I converting enzyme II or ACE2, also known as ACEH, is part of the renin-angiotensin system, which regulates blood pressure, and the balance of fluids and salts in the body.[1]
Contents
Function[edit | edit source]
The ACE2 encoding gene is believed to have a role in the carcardiovascular/circulatory system, kidney function, and fertility.[1][2]
ACE2 cuts the angiotensin I protein, convert it into angiotensin II.[1][2]
ME/CFS[edit | edit source]
Lieberman and Bell (1992) found higher serum ACE2 levels in 80% of patients with ME/CFS, compared to 9.4% of controls.[3]
POTS[edit | edit source]
Musafa et al. (2012) found some patients with POTS have "inappropriately high plasma angiotensin II levels", and estimated that these patents had low ACE2 activity.[4]
COVID-19[edit | edit source]
SARS-CoV-2, the virus that causes COVID-19, uses ACE2 receptors to binds to human cell.[5] Yan et al 2020) suggest that blocking ACE2 receptors may potentially prevent SARS-CoV-2 infection.[5]
Notable studies[edit | edit source]
- 1992, Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: A comparison to serum angiotensin-converting enzyme in sarcoidosis
- 2012, Abnormalities of Angiotensin Regulation in Postural Tachycardia Syndrome
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
serum The clear yellowish fluid that remains from blood plasma after clotting factors have been removed by clot formation. (Blood plasma is simply blood that has had its blood cells removed.)
postural orthostatic tachycardia syndrome (POTS) - A form of orthostatic intolerance where the cardinal symptom is excessive tachycardia due to changing position (e.g. from lying down to sitting up).
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
